Arrhythmias-Targeting Compound 1

• UNSPSC Description:

  Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, extracted from patent WO 2001028992 A2.

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/Benzonitrile,_4-[[3-[7-_3,3-dimethyl-2-oxobutyl_-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]propyl]amino]-.html

• Solubility:

  10 mM in DMSO

• Smiles:

  N#CC1=CC=C(NCCCN2CC(O3)CN(CC(C(C)(C)C)=O)CC3C2)C=C1

• Molecular Weight:

  384.52

• References & Citations:

  [1]Björe, Annika, et al. NEW OXABISPIDINE COMPOUNDS USEFUL IN THE TREATMENT OF CARDIAC ARRHYTHMIAS. WO 2001028992 A2.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  335619-12-0